PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,092 | +26.8% | 36,917 | +70.2% | 0.00% | 0.0% |
| Q2 2023 | $76,573 | -82.1% | 21,692 | -84.3% | 0.00% | -66.7% |
| Q1 2023 | $426,970 | +33.8% | 138,178 | +83.2% | 0.00% | +50.0% |
| Q4 2022 | $319,103 | +459.8% | 75,438 | +212.6% | 0.00% | – |
| Q3 2022 | $57,000 | -71.4% | 24,136 | -65.5% | 0.00% | -100.0% |
| Q2 2022 | $199,000 | +77.7% | 69,938 | +80.2% | 0.00% | 0.0% |
| Q1 2022 | $112,000 | -17.6% | 38,806 | -13.5% | 0.00% | 0.0% |
| Q4 2021 | $136,000 | -39.0% | 44,867 | +41.0% | 0.00% | -66.7% |
| Q3 2021 | $223,000 | -53.9% | 31,824 | -39.6% | 0.00% | -40.0% |
| Q2 2021 | $484,000 | +148.2% | 52,694 | +162.4% | 0.01% | +150.0% |
| Q1 2021 | $195,000 | -7.1% | 20,082 | -0.2% | 0.00% | -50.0% |
| Q2 2020 | $210,000 | -70.5% | 20,125 | -76.1% | 0.00% | -78.9% |
| Q1 2020 | $711,000 | +5.5% | 84,209 | +9.3% | 0.02% | +58.3% |
| Q4 2019 | $674,000 | +17.4% | 77,010 | +44.5% | 0.01% | +9.1% |
| Q3 2019 | $574,000 | -55.1% | 53,277 | -47.1% | 0.01% | -52.2% |
| Q2 2019 | $1,279,000 | +28.3% | 100,663 | +291.7% | 0.02% | -28.1% |
| Q1 2019 | $997,000 | +823.1% | 25,697 | +384.8% | 0.03% | +540.0% |
| Q4 2018 | $108,000 | -70.7% | 5,300 | -34.0% | 0.01% | -75.0% |
| Q3 2018 | $368,000 | +1433.3% | 8,035 | +1908.8% | 0.02% | +1900.0% |
| Q2 2018 | $24,000 | -68.0% | 400 | -63.7% | 0.00% | -75.0% |
| Q1 2018 | $75,000 | -63.4% | 1,102 | -47.0% | 0.00% | -63.6% |
| Q4 2017 | $205,000 | +72.3% | 2,078 | +109.9% | 0.01% | +57.1% |
| Q3 2017 | $119,000 | -18.5% | 990 | -40.6% | 0.01% | -22.2% |
| Q2 2017 | $146,000 | -13.6% | 1,668 | -69.8% | 0.01% | -30.8% |
| Q4 2016 | $169,000 | +160.0% | 5,521 | +472.1% | 0.01% | +225.0% |
| Q3 2016 | $65,000 | -39.8% | 965 | -73.3% | 0.00% | -33.3% |
| Q2 2016 | $108,000 | -91.2% | 3,610 | -91.4% | 0.01% | -91.4% |
| Q1 2016 | $1,228,000 | +113.6% | 41,809 | +469.6% | 0.07% | +105.9% |
| Q4 2015 | $575,000 | +492.8% | 7,340 | +467.7% | 0.03% | +580.0% |
| Q3 2015 | $97,000 | -92.2% | 1,293 | -87.8% | 0.01% | -91.8% |
| Q2 2015 | $1,238,000 | +435.9% | 10,603 | +984.2% | 0.06% | +454.5% |
| Q1 2015 | $231,000 | +1.8% | 978 | -18.5% | 0.01% | -8.3% |
| Q4 2014 | $227,000 | – | 1,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |